BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1713944)

  • 1. Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin.
    Wilks JW; Scott PS; Vrba LK; Cocuzza JM
    Int J Radiat Biol; 1991; 60(1-2):73-7. PubMed ID: 1713944
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of angiogenesis by suramin.
    Gagliardi A; Hadd H; Collins DC
    Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization.
    McNatt LG; Weimer L; Yanni J; Clark AF
    J Ocul Pharmacol Ther; 1999 Oct; 15(5):413-23. PubMed ID: 10530702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
    Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
    Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.
    Crum R; Szabo S; Folkman J
    Science; 1985 Dec; 230(4732):1375-8. PubMed ID: 2416056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.
    Chen NT; Corey EJ; Folkman J
    Lab Invest; 1988 Oct; 59(4):453-9. PubMed ID: 2459497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiogenesis by aurintricarboxylic acid.
    Gagliardi AR; Collins DC
    Anticancer Res; 1994; 14(2A):475-9. PubMed ID: 7517120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiostatic steroid with or without glucocorticoid activity on metastasis.
    Sakamoto N; Tanaka NG
    Invasion Metastasis; 1987; 7(4):208-16. PubMed ID: 2444551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.
    Ingber DE; Madri JA; Folkman J
    Endocrinology; 1986 Oct; 119(4):1768-75. PubMed ID: 2428602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis through modulation of collagen metabolism.
    Ingber D; Folkman J
    Lab Invest; 1988 Jul; 59(1):44-51. PubMed ID: 2455830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.
    Pesenti E; Sola F; Mongelli N; Grandi M; Spreafico F
    Br J Cancer; 1992 Aug; 66(2):367-72. PubMed ID: 1380282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of angiogenesis with synthetic heparin substitutes.
    Folkman J; Weisz PB; JoulliƩ MM; Li WW; Ewing WR
    Science; 1989 Mar; 243(4897):1490-3. PubMed ID: 2467380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat.
    Proia AD; Hirakata A; McInnes JS; Scroggs MW; Parikh I
    Exp Eye Res; 1993 Dec; 57(6):693-8. PubMed ID: 7512045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
    Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
    Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis.
    Pepper MS; Vassalli JD; Wilks JW; Schweigerer L; Orci L; Montesano R
    J Cell Biochem; 1994 Aug; 55(4):419-34. PubMed ID: 7525617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiostatic activity and metabolism of cortisol in the chorioallantoic membrane (CAM) of the chick embryo.
    McNatt LG; Lane D; Clark AF
    J Steroid Biochem Mol Biol; 1992 Aug; 42(7):687-93. PubMed ID: 1380295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiostatic steroids. Method of discovery and mechanism of action.
    Folkman J; Ingber DE
    Ann Surg; 1987 Sep; 206(3):374-83. PubMed ID: 2443088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine.
    Arrieta O; Guevara P; Reyes S; Ortiz A; Rembao D; Sotelo J
    Eur J Cancer; 1998 Dec; 34(13):2101-6. PubMed ID: 10070318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.
    Maione TE; Gray GS; Petro J; Hunt AJ; Donner AL; Bauer SI; Carson HF; Sharpe RJ
    Science; 1990 Jan; 247(4938):77-9. PubMed ID: 1688470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.